Prof. Dr. med. Georg Schett

Lehrstuhl für Innere Medizin III

INHIBITION OF ARGINASE-1 EXPRESSION BY THE TRANSCRIPTION FACTOR FRA-1 IN MACROPHAGES EXACERBATES RHEUMATOID ARTHRITIS INFLAMMATION (2019) Hannemann N, Cao S, Schnelzer A, Jordan J, Eberhardt M, Schleicher U, Uebe S, et al. Conference contribution Checkpoint Inhibitors The Diagnosis and Treatment of Side Effects (2019) Heinzerling L, De Toni EN, Schett G, Hundorfean G, Zimmer L Journal article, Review article To NET or not to NET: current opinions and state of the science regarding the formation of neutrophil extracellular traps (2019) Boeltz S, Amini P, Anders HJ, Andrade F, Bilyy R, Chatfield S, Cichon I, et al. Journal article, Review article Erdheim-Chester disease. An important differential diagnosis and its main symptoms (2019) Knitza J, Kampylafka E, Wacker J, Schett G, Manger B Journal article The need for comparative data in spondyloarthritis (2019) Choy E, Baraliakos X, Behrens F, D'Angelo S, De Vlam K, Kirkham BW, Ostergaard M, et al. Journal article THE ROLE OF THE IL-23/TH17 AXIS AS MODULATOR OF B CELL-MEDIATED (AUTO)IMMUNE RESPONSES (2019) Pfeifle R, Kittler J, Rothe T, Schett G, Krönke G Conference contribution SECUKINUMAB PROVIDES RAPID AND SUSTAINED RESOLUTION OF ENTHESITIS IN PSORIATIC ARTHRITIS PATIENTS: POOLED ANALYSIS OF TWO PHASE 3 STUDIES, FUTURE 2 AND FUTURE 3 (2019) Coates LC, Mcgonagle D, Schett G, Mease PJ, Quebe-Fehling E, Asquith DL, Rasouliyan L, et al. Conference contribution PHYSICAL FUNCTION IN RA PATIENTS IN REMISSION UNDERGOING TAPERING AND/OR STOPPING OF DMARDS (2019) Stephan M, Tascilar K, Hagen M, Haschka J, Reiser M, Kleyer A, Manger B, et al. Conference contribution IMPACT OF SECUKINUMAB TREATMENT ON PSORIATIC ARTHRITIS PATIENTS WITH OR WITHOUT ENTHESITIS AT BASELINE: POOLED DATA FROM FUTURE 2 AND FUTURE 3 PHASE 3 STUDIES (2019) Mcinnes IB, Wallman JK, Schett G, Quebe-Fehling E, Rasouliyan L, Pricop L, Fasth AE, Gaillez C Conference contribution ACUTE PHASE REACTANT LEVELS AND PREDNISONE DOSES AT DISEASE FLARE IN PATIENTS WITH GIANT CELL ARTERITIS: PROSPECTIVE DATA FROM THE GIACTA TRIAL (2019) Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, et al. Conference contribution